IN-HAMP

About Indiana Hepatitis Academic Mentorship Program

This program has been rebranded as TREAT. Please visit our TREAT page for up-to-date information. 

IN-HAMP featured two full days of training & medical education for clinicians & healthcare professionals who were new to treating hepatitis C. The program included two 1.5-hour-long Hepatitis C ECHO sessions.

The four components of IN-HAMP:

  1. Cycle 1: A full day of training and medical education after which participants will have the resources and support to immediately begin treating patients for HCV. 
  2. Cycle 2: A second day of training with advanced topics which occurs > 6 months after cycle 1. 
  3. Real-time & individualized HCV mentorship with specialists in hepatology, pharmacology, internal medicine, primary care, social work, and linkage to care. 
  4. Ongoing continuing education in connection with the Hepatitis C ECHO. 

IN-HAMP included individual and real-time HCV mentorship with specialists in hepatology, internal medicine, pharmacology, and social work. All clinical providers treating patients living with HCV were invited to participate in both full training days (Cycle 1 & Cycle 2) and HCV ECHO sessions.

IN HAMP logo

Program Outlook

cycle 1 to cycle 2 training outlook

Education Credits

No-cost specialty continuing education credits were available for physicians, pharmacists, nurses, and social workers with the Indiana University School of Medicine Division of Continuing Education in Healthcare Professions. 

This activity had been approved for AMA PRA Category 1 Credit(s)™ by Indiana University School of Medicine.

Cycle I Agenda

A virtual event hosted via Zoom.

Welcome & Introduction; Indiana HCV Epidemiologic Profile
Screening & Evaluation of Potential HCV Infection
The New Era of Direct-Acting Antiviral Treatments
Medication Access: What You Need To Know
Manifestations of Viral Hepatitis B & C in Pregnancy (HCV ECHO)
A Focus on Infants & Children: The Latest Treatment Updates
Using REDCap Overview
Caring for People with High-Risk HCV & Linkage to Care
Connecting to National Harm Reduction & HCV Elimination Efforts
Staging Liver Disease in People Living with HCV
Next Steps: Getting Started with Treatment with IN-HAMP Mentorship Support

Cycle II Agenda

An in-person event at the IU Richard M. Fairbanks School of Public Health

Registration & Breakfast
Welcome & Introductions
Drug-to-Drug Interaction Workarounds
Optional: Commercial Sponsor Event
Pharmacology: Naloxone
Lunch Break
Hepatitis C ECHO
Afternoon Break
HCV and Other Liver Disease Overlap
Your Role In Harm Reduction & HCV Elimination
Overarching Review of Important Points of Today's Presentation

Resources will be available on Canvas. 

Our Goals

  1. Educate and train healthcare professionals to screen, diagnose, treat, and follow up with patients living with hepatitis C.
  2. Improve individuals' health in communities across Indiana, especially amongst minority and underserved populations.
  3. Collaborate with experts and learners in healthcare and public health spaces to share best practices, provide resources, and champion health.
  4. Advocate for hepatitis C elimination through training and education with a broad range of care collaborations.
  5. Empower learners to discuss what they know and what they don't know, bridge the knowledge gap, and share in a safe environment amongst peers.

Partnership

The IU Indianapolis ECHO Center hosted the Indiana Hepatitis Academic Mentorship Program in partnership with US-HAMP, the Indiana Department of Health, and the Midwest AIDS Training + Education Center (MATEC Indiana). IN HAMP was sponsored by AbbVie and Gilead.